miR-192 directly binds and regulates Dicer1 expression in neuroblastoma

Galina Feinberg-Gorenshtein, Avital Guedj, Keren Shichrur, Marta Jeison, Drorit Luria, Yona Kodman, Shifra Ash, Meora Feinmesser, Liat Edry, Noam Shomron, Abraham Weizman, Isaac Yaniv, Smadar Avigad

Research output: Contribution to journalArticlepeer-review


Neuroblastoma (NB) arises from the embryonic neural crest and is the most common extracranial solid tumor in children under 5 years of age. Reduced expression of Dicer1 has recently been shown to be in correlation with poor prognosis in NB patients. This study aimed to investigate the mechanisms that could lead to the down-regulation of Dicer1 in neuroblastoma. We used computational prediction to identify potential miRs down-regulating Dicer1 in neuroblastoma. One of the miRs that were predicted to target Dicer1 was miR-192. We measured the levels of miR-192 in 43 primary tumors using real time PCR. Following the silencing of miR-192, the levels of dicer1 cell viability, cell proliferation and migration capability were analyzed. Multivariate analysis identified miR-192 as an independent prognostic marker for relapse in neuroblastoma patients (p=0.04). We were able to show through a dual luciferase assay and side-directed mutational analysis that miR-192 directly binds the 3' UTR of Dicer1 on positions 1232-1238 and 2282-2288. An increase in cell viability, proliferation and migration rates were evident in NB cells transfected with miR-192-mimic. Yet, there was a significant decrease in proliferation when NB cells were transfected with an miR-192-inhibitor We suggest that miR-192 might be a key player in NB by regulating Dicer1 expression.

Original languageEnglish
Article numbere78713
JournalPLoS ONE
Issue number11
StatePublished - Nov 2013


Dive into the research topics of 'miR-192 directly binds and regulates Dicer1 expression in neuroblastoma'. Together they form a unique fingerprint.

Cite this